Kathleen M Hayden
Overview
Explore the profile of Kathleen M Hayden including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
133
Citations
2660
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lockhart S, Sutphen C, Tanley J, Gonzalez-Ortiz F, Kac P, Habes M, et al.
medRxiv
. 2025 Feb;
PMID: 39990571
Introduction: Little is known about how Alzheimer's disease (AD) plasma biomarkers relate to cerebral small vessel disease (cSVD) neuroimaging biomarkers. Methods: The study involved 251 Wake Forest Multi-Ethnic Study of...
2.
Martinez-Amezcua P, Zhang W, Assi S, Gupta H, Twardzik E, Huang A, et al.
J Gerontol A Biol Sci Med Sci
. 2025 Feb;
PMID: 39953975
Background: Age-related hearing loss is common among older adults and may influence physical activity and sedentary behaviors, such as TV viewing. This study examined whether a hearing intervention could affect...
3.
Moseholm K, Jensen M, Buzkova P, Aroner S, Fitzpatrick A, Longstreth Jr W, et al.
Neurobiol Aging
. 2025 Feb;
148:71-79.
PMID: 39951847
Circulating non-esterified fatty acids (NEFAs) have toxic effects on a variety of organs central to cardiometabolic disease and can cross the blood-brain barrier. Whether NEFAs associate with cognitive decline or...
4.
Mielke M, Evans J, Neiberg R, Molina-Henry D, Marcovina S, Johnson K, et al.
JAMA Netw Open
. 2025 Feb;
8(2):e2458149.
PMID: 39913137
Importance: Blood-based biomarkers (BBMs) are clinically available to aid in the diagnosis of Alzheimer disease (AD) and AD-related dementias (ADRD), but their association with cognition among older adults with specific...
5.
Steens I, Ji Y, Sedaghat S, Pankow J, Klein B, Cotch M, et al.
Diabetes Obes Metab
. 2025 Jan;
27(4):2299-2304.
PMID: 39888145
No abstract available.
6.
Domingo-Relloso A, McGraw K, Heckbert S, Luchsinger J, Schilling K, Glabonjat R, et al.
JAMA Netw Open
. 2024 Dec;
7(12):e2448286.
PMID: 39621345
Importance: Metals are established neurotoxicants, but evidence of their association with cognitive performance at low chronic exposure levels is limited. Objective: To investigate the association of urinary metal levels, individually...
7.
Chevli P, Schaich C, Wood A, Tk L, Mehta A, Jain V, et al.
Alzheimers Dement (Amst)
. 2024 Nov;
16(4):e70039.
PMID: 39583649
Introduction: Growing interest centers on the association between circulating ketone bodies (KB) and cognitive function, notably in aging and neurodegenerative diseases. Methods: Associations of plasma KB with incident dementia and...
8.
Huang A, Morales E, Arnold M, Burgard S, Couper D, Deal J, et al.
JAMA Netw Open
. 2024 Nov;
7(11):e2446591.
PMID: 39570588
Importance: Health-related quality of life is a critical health outcome and a clinically important patient-reported outcome in clinical trials. Hearing loss is associated with poorer health-related quality-of-life in older adults....
9.
Besser L, Forrester S, Arabadjian M, Bancks M, Culkin M, Hayden K, et al.
PLoS One
. 2024 Nov;
19(11):e0313625.
PMID: 39556532
Background: Researchers have increasingly recognized the importance of structural and social determinants of health (SSDOH) as key drivers of a multitude of diseases and health outcomes. The Multi-Ethnic Study of...
10.
Walker K, An Y, Moghekar A, Moaddel R, Duggan M, Peng Z, et al.
Mol Neurodegener
. 2024 Nov;
19(1):81.
PMID: 39482741
Background: Apolipoprotein E (APOE) ε4 allele is the strongest genetic risk factor for late onset Alzheimer's disease (AD). This case-cohort study used targeted plasma biomarkers and large-scale proteomics to examine...